Our person-centric approach in HIV research prioritizes long-term studies and real-world evidence and considers the intersection of efficacy, adherence and resistance in #HIV treatment. Watch to learn more. #AIDS2024 | #PutPeopleFirst
Gilead Sciences
Biotechnology Research
Foster City, CA 631,262 followers
Creating Possible
About us
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Foster City, CA
- Type
- Public Company
- Founded
- 1987
Locations
Employees at Gilead Sciences
Updates
-
#GileadNews: At #AIDS2024, we’re presenting new efficacy and safety data from the unprecedented PURPOSE 1 trial for our long-acting, investigational medication for HIV prevention. Learn more about our efforts as we move closer to ending the HIV epidemic: https://gilead.inc/4dclWB5
-
Today, we’re announcing a further five-year $25 million commitment to RADIAN, our collaboration with the Elton John AIDS Foundation to address the HIV crisis in Eastern Europe and Central Asia. Together, we can help end the epidemic. https://gilead.inc/46hVHqo
Gilead Sciences and EJAF announce a further five-year RADIAN partnership
-
With HIV diagnosis rates at approximately 90%, HIV experts in Germany united through a Gilead initiative to bridge the final gap. Watch the full video: https://gilead.inc/3We4oh5 #AIDS2024 | #PutPeopleFirst
Working Together to Help End the HIV Epidemic
-
We're committed to transformational collaborations at the global, national and local levels that aim to help address the diverse health needs and preferences of those affected by #HIV. Jared Baeten, SVP, Clinical Development, Virology, sat down with New Scientist to talk about Gilead’s commitment to person-centric innovation that extends beyond the lab. https://gilead.inc/4f5UOp4 #AIDS2024 | #PutPeopleFirst
Hear about the critical intersection of scientific innovation and health equity
-
For the fifth year, we’re on the Seramount 100 Best Companies list for our inclusive workplace and culture. Investing in our people can inspire a healthier and happier workforce that drives collaboration and impact. “Our people are our greatest asset and prioritizing their wellbeing is a cornerstone of Gilead’s culture. That’s why we continue to offer comprehensive benefits, create a supportive work environment and advocate for a healthy work-life balance,” says Jyoti Mehra, Executive Vice President, Human Resources. #Seramount100Best
-
#GileadNews: We’ll share data from our research and development programs and collaborations at #AIDS2024, underscoring our commitment to a person-centered approach to help advance progress toward ending the HIV epidemic. https://gilead.inc/3W4HGrE
-
At The Hollywood Reporter Social Impact Summit last week, a panel discussion focused on the importance of using public platforms for good and the ways community organizations, advocates, celebrities and business leaders can work together to help end the HIV epidemic. “By leveraging their large platforms to amplify HIV awareness and education, public figures play an essential role in reducing stigma and engaging their followers,” said panelist Carmen Villar, VP, ESG and Corporate Citizenship at Gilead.
-
Last month marked Gilead's Month of Service, an annual tradition where employees step away from their desks and work alongside local organizations to make an impact in their communities. Our service activities included gardening and landscaping, assembling backpacks and STEM supply kits for children, building homes, providing art and science classes to children living with HIV and viral hepatitis and packing meals at food banks. By actively engaging with communities in need, we get closer to our vision of a healthier world for all people.
-
Gilead and Kite Pharma have been recognized by the Association of Energy Engineers and named recipients of the 2024 International and Regional Awards for outstanding contributions to the field of energy efficiency and sustainability. Our passion for creating a better, healthier world drives us to be responsible corporate citizens.
Affiliated pages
Similar pages
Browse jobs
Stock
GILD
NASDAQ
20 minutes delay
$73.50
2.33 (3.274%)
- Open
- 71.66
- Low
- 71.42
- High
- 73.6
Data from Refinitiv
See more info on